AU

Ateeq Ur Rehman

Active Director Director DIN 09369515
DIN 09369515 First appointment Oct 2021 Primary industry Healthcare
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Oct 2021
Shareholding value •••• Premium profile

About Ateeq Ur Rehman

Data last updated:

Ateeq Ur Rehman is a Director at Biolocus Pharma Private Limited (since 2021). The company operates in Healthcare. Biolocus Pharma Private Limited reported revenue of ₹16 Lakh (FY 2024).

DIN 09369515
Primary Designation Director
Industry Healthcare
First Appointment 22 Oct 2021
Oldest Company Age 5 yrs
Largest company Biolocus Pharma Private Limited · ₹16 Lakh (FY 2024)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Biolocus Pharma Private Limited U85110DL2021PTC388668
Director22 Oct 20212021₹16 Lakh (FY 2024)Active

Board colleagues of Ateeq Ur Rehman

Directorship timeline

Open interactive timeline →
Biolocus Pharma Private Limited
Premium access

Shareholding and investment profile for Ateeq Ur Rehman

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Ateeq Ur Rehman

Ateeq Ur Rehman currently holds 1 directorship: Biolocus Pharma Private Limited (Director, since 22 Oct 2021, revenue ₹16 Lakh (FY 2024)).

Ateeq Ur Rehman was first appointed on 22 Oct 2021 as Director at Biolocus Pharma Private Limited.

The current boards of Ateeq Ur Rehman's companies include Mohammad Imran (Biolocus Pharma Private Limited), Mohammed Danish Abdul Wahab (Biolocus Pharma Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available